Laboratory Validation for Hereditary Tyrosinemia 1 (HT1)
Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories.
Buyer
NHS England
Value
£26,523
Published
23 Apr 2024
Closes
31 Dec 2023
Procurement details
Source
Contracts Finder
Region
England
Procurement method
Direct
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85111810
Blood analysis services
Lots
Lot default Laboratory Validation for Hereditary Tyrosinemia 1 (HT1)
£26,523
Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories.
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
23 Apr 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.